Phase II study of pegylated liposomal doxorubicin (Caelyx&unknown;) as induction chemotherapy for patients with squamous cell cancer of the head and neck

Author: Harrington K.J.   Lewanski C.   Northcote A.D.   Whittaker J.   Peters A.M.   Vile R.G.   Stewart J.S.W.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.37, Iss.16, 2001-11, pp. : 2015-2022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content